GeneDx Holdings Corp

GeneDx insider moves show routine RSU conversions and CFO buying, indicating confidence in AI‑driven genomics, but investors face a negative P/E and price decline.

GeneDx insider selling surge: COO Dechairo Bryan offloads 7,759 shares amid price plunge—what it signals for investors and the company’s future.

GeneDx insider trading: COO Dechairo Bryan’s buy‑sell actions reveal tax‑covering moves and an upcoming RSU award, hinting at management’s confidence and future stake growth.